Systematic Evaluation of Canadian Diabetes Smartphone Applications for People With Type 1, Type 2 and Gestational Diabetes.


Journal

Canadian journal of diabetes
ISSN: 2352-3840
Titre abrégé: Can J Diabetes
Pays: Canada
ID NLM: 101148810

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 27 10 2019
revised: 04 06 2020
accepted: 23 07 2020
pubmed: 1 11 2020
medline: 16 11 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

Our aims in this study were to: 1) review diabetes apps available in Canada using the Mobile App Rating Scale tool and generate usability scores for each, 2) characterize availability of features across all apps, 3) evaluate the clinical safety of bolus insulin calculators and 4) evaluate the quality of exportable blood glucose reports meant for use by health-care providers. Two primary reviewers searched for, screened and evaluated diabetes apps from the Android Play Store and iOS App Store, resulting from the search terms "glucose" and "diabetes." Overall Mobile App Rating Scale quality rating score was 3.1 out of 5. The Functionality subsection scored the highest (3.9 out of 5) and Information scored the lowest (2.0 out of 5). The majority of apps have the ability to track carbohydrate intake (54 of 75, 72%), send reminders (46 of 75, 61%) and can generate blood glucose reports (53 of 75, 71%), but few have bolus insulin calculators (6 of 75, 9%) and remote diabetes support (10 of 75, 13%). Despite the widespread availability of many iOS and Android diabetes management apps, few are of high quality.

Identifiants

pubmed: 33127288
pii: S1499-2671(20)30225-2
doi: 10.1016/j.jcjd.2020.07.005
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-178.e1

Informations de copyright

Copyright © 2020 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Mary Nguyen (M)

Division of Endocrinology and Metabolism, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Nafis Hossain (N)

Western University, London, Ontario, Canada.

Rohin Tangri (R)

Western University, London, Ontario, Canada.

Jay Shah (J)

Western University, London, Ontario, Canada.

Payal Agarwal (P)

Department of Family Medicine, Women's College Hospital, Toronto, Ontario, Canada.

Fiona Thompson-Hutchison (F)

Division of Endocrinology and Metabolism, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Ilana Halperin (I)

Division of Endocrinology and Metabolism, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address: ilana.halperin@sunnybrook.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH